Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study

McLaren J, Chon Y, Gorski KS, Bernstein JA, Corren J, Hayama K, Jain V, Lima H, Sofen H, Ponnarambil S, Molfino NA, Maurer M. Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study. J Allergy Clin Immunol. 2025 Feb 14:S0091-6749(25)00172-1. doi: 10.1016/j.jaci.2025.01.045. Epub ahead of print. PMID: 39956278.


Related Posts